573108 Sigma-AldrichSTAT5 Inhibitor - CAS 285986-31-4 - Calbiochem
STAT5 Inhibitor, CAS 285986-31-4, is a cell-permeable compound that selectively targets the SH2 domain of STAT5 (IC50 = 47 µM against STAT5b SH2 domain EPO peptide binding activity).
More>> STAT5 Inhibitor, CAS 285986-31-4, is a cell-permeable compound that selectively targets the SH2 domain of STAT5 (IC50 = 47 µM against STAT5b SH2 domain EPO peptide binding activity). Less<<Synonymes: Nʹ-((4-Oxo-4H-chromen-3-yl)methylene)nicotinohydrazide
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
CAS # | Empirical Formula |
---|---|
285986-31-4 | C₁₆H₁₁N₃O₃ |
Products
Référence | Conditionnement | Qté | |
---|---|---|---|
573108-10MG | Ampoule plast. | 10 mg |
References | |
---|---|
References | Muller, J., et al. 2008. ChemBioChem 9, 723. |
Product Information | |
---|---|
CAS number | 285986-31-4 |
Form | White solid |
Hill Formula | C₁₆H₁₁N₃O₃ |
Chemical formula | C₁₆H₁₁N₃O₃ |
Structure formula Image | |
Quality Level | MQ100 |
Biological Information | |
---|---|
Purity | ≥97% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Référence | GTIN |
573108-10MG | 04055977265941 |
Documentation
STAT5 Inhibitor - CAS 285986-31-4 - Calbiochem FDS
Titre |
---|
STAT5 Inhibitor - CAS 285986-31-4 - Calbiochem Certificats d'analyse
Titre | Numéro de lot |
---|---|
573108 |
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Muller, J., et al. 2008. ChemBioChem 9, 723. |
Brochure
Titre |
---|
An Introduction to Inhibitors and Their Biological Applications - 1st Edition |
Informations techniques
Titre |
---|
JAK/STAT Signaling Research Focus |